Venus Remedies share price hit an intraday high of Rs 355 per share, rising 6 per cent on the BSE in Monday’s intraday trade. This came after the company on Friday said that it has secured marketing authorization for Pemetrexed 500mg, a chemotherapeutic agent widely used in the treatment of...